Maddy summaryThe Preserve Access to Affordable Generics and Biosimilars Act prohibits "reverse payment" settlements where brand-name drug companies pay generic competitors to delay market entry, treating such agreements as anticompetitive violations of the Federal Trade Commission Act. The bill empowers the FTC to enforce these rules through civil penalties that can reach up to three times the value transferred in the settlement and allows for the forfeiture of a generic company's 180-day exclusivity period if they violate the new law. It also requires executives to certify that all settlement documents filed with regulators are complete and accurate, including any related oral agreements or contingent conditions. These provisions apply to both traditional generic drugs and biosimilar biological products to ensure that patent disputes do not unduly restrict consumer access to lower-cost alternatives.
Sponsored bills
Maddy summaryS 148, the Stop STALLING Act, targets pharmaceutical companies that file sham petitions to delay generic drug approvals. It authorizes the Federal Trade Commission (FTC) to penalize companies submitting objectively baseless petitions under FDA drug approval processes, which are deemed to interfere with competitors' business. Penalties include up to $50,000 per day a sham petition was under review or revenue from drug sales during the delay. The bill directly affects brand-name drug manufacturers (who may file such petitions) and generic drug developers (who face delays), with enforcement triggered by the Secretary of Health and Human Services' determination of delay intent. It applies to petitions filed after enactment and does not alter existing antitrust laws.
Maddy summaryThis bill directs the Federal Trade Commission (FTC) to study and report on practices in the pharmaceutical supply chain, focusing on pharmacy benefit managers (PBMs) and their impact on drug pricing. The FTC must submit an interim report within 180 days and a full report within one year, examining issues like whether PBMs steer patients to pharmacies they own, use proprietary data for competitive advantage, or design formularies to favor higher-cost drugs. The reports will also assess competition in the supply chain, legal barriers to enforcement, and the FTC’s ability to address anticompetitive behavior by drug manufacturers. The goal is to identify transparency gaps and recommend policy changes to improve competition and ensure consumers benefit from cost savings.
Maddy summaryThis bill establishes a formal coordination framework between federal agencies to streamline patent applications and reduce duplication of efforts. It requires agencies to share information about their patent activities and creates a centralized system for tracking and managing intellectual property across the government. The legislation applies to all federal departments and agencies that file patents, aiming to improve efficiency and consistency in how the government protects its innovations.
Maddy summaryThis bill authorizes Congress to award a single gold medal to the First Rhode Island Regiment collectively, recognizing their service during the Revolutionary War. The medal, designed by the Treasury Secretary, will be permanently displayed at the Rhode Island State Library, with Congress encouraging its use for research and potential display at other historically significant locations. Bronze duplicates may be sold to cover production costs, and all medals are classified as national medals under U.S. law. The bill directly honors the regiment, which in 1778 became one of the first integrated units in American history by recruiting over 200 Black and Indigenous soldiers.
Haiti Economic Lift Program Extension Act of 2023 This bill extends through FY2035 the special duty-free rules for Haiti. It also extends through FY2035 the duty-free treatment provided for certain apparel products assembled in and imported from Haiti.
Maddy summaryThe Air Carrier Access Amendments Act of 2023 updates the 1986 Air Carrier Access Act to improve air travel accessibility for people with disabilities. It requires airlines to provide accessible aircraft with features like wheelchair restraints, accessible seating, and proper stowage for assistive devices within seven years, and mandates new accessibility standards for airport facilities, digital interfaces, and in-flight communications. The bill creates a private right of action allowing individuals to sue airlines for discrimination, establishes a formal complaint process with 120-day investigation timelines, and sets civil penalties for specific violations like damaging assistive devices or denying boarding. These changes directly affect airlines and travelers with disabilities by strengthening enforcement mechanisms and modernizing accessibility requirements that have not been updated since the original law.
Maddy summaryThis bill requires major airlines (defined as carriers with over $1.5 billion in 2018 revenue or foreign carriers operating U.S. flights) to provide full cash refunds - including ancillary fees - for canceled flights or tickets canceled 48+ hours before departure. Passengers who received vouchers during the pandemic (March 2020-enactment) can now request cash refunds for unused portions within 30 days. Airlines must clearly disclose refund rights before ticket sales and during cancellations, with violations carrying $1,000 penalties per incident. The law applies to all covered flights departing from or arriving at U.S. airports.
Maddy summaryThis bill requires the removal of statues in the U.S. Capitol that honor individuals who served in the Confederate States of America. The Architect of the Capitol must identify and remove these statues within 120 days of enactment, with states able to request the return of statues they provided (at their own cost) or have them stored by the Capitol. The bill appropriates $2 million for removal, transfer, storage, and security costs related to the process. It directly affects the Capitol's display of statues, the Architect of the Capitol, and states that originally contributed such statues. The law amends existing rules to exclude Confederate service from eligibility for Capitol statues.
Maddy summaryThe DAIRY PRIDE Act (S 549) amends federal food labeling rules to prevent plant-based products from using dairy-related terms like "milk," "yogurt," or "cheese" unless they meet the FDA's definition of dairy: derived from the lacteal secretion of hooved mammals (e.g., cows). It directly affects manufacturers of plant-based alternatives (e.g., almond, oat, or coconut milk) that currently label products with dairy terms. The bill requires the FDA to enforce this definition through new guidance within 180 days of enactment, clarifying that products not meeting the standard cannot be marketed as dairy. It does not change nutritional requirements but aims to reduce consumer confusion about product composition.